Latest news
ImmunityBio (IBRX) Stock Looks Rich On Sales But Strong On Returns - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 08:14:11 GMTThe Bull Case For ImmunityBio (IBRX) Could Change Following ANKTIVA’s Broad UAE Approval And Ongoing Losses - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 06:14:00 GMTIBRX Q2 Earnings & Sales Beat Estimates on Strong Anktiva Uptake - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 14:53:00 GMTImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:30:00 GMTIBRX Stock Sees Sharp UAE-Driven Jump Followed By Early August Pullback - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 23:47:46 GMTImmunityBio, Inc. (IBRX) Options Chain - Yahoo! Finance CanadaYahoo! Finance Canada · Mon, 03 Aug 2026 11:13:48 GMT